Navigation Links
NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
Date:4/8/2013

cations in Europe will provide flexibility for capacity management as well as risk protection.

Progress in Corporate MattersThe Company added a highly respected pharma industry veteran, Dr. Guenter Rosskamp, to its management team as CEO of the Company's German subsidiary.  Dr. Rosskamp previously served for many years as Head of Central Nervous System Therapeutics, and as head of Strategic Business Development, for Schering AG (now part of Bayer AG).  In those capacities, Dr. Rosskamp was responsible for the development and commercialization of multiple drugs.

The Company expanded its Board in 2012 with highly two respected experts:  Dr. Navid Malik and Mr. Jerry Jasinowski.  Dr. Malik is Head of Life Sciences Research for Cenkos Securities Plc. in the UK, and has been one of the most influential analysts in the UK and Europe over the last decade, covering the life sciences industry worldwide.  Mr. Jasinowski is a nationally recognized chief executive who headed up the largest industrial trade association in the US (the National Association of Manufacturers) for fourteen years, and has extensive board experience across a wide range of manufacturing, technology, and financial firms, including Fortune 1000 and Fortune 500 companies.

Progress in Intellectual Property – PatentsA dozen new patents were issued to the Company in 2012 as part of its worldwide patent portfolio of over 180 issued and pending patents.  The newly issued patents covered a variety of subject matter, such as the proprietary partial maturation for DCVax-Direct, the machines and systems to manufacture DCVax-Direct, processes for enhancing the potency of dendritic cells in general, measures of product quality, and other.

Progress in FinancingDuring 2012, the Company completed a comprehensive clean-up of its balance sheet, through which it removed the vast majority of all investor debt.  The Company continued to carry trade payable
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
2. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
3. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
4. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
5. Professional Pricing Society Explores New Role of Pricers as Change Agents and Leaders at 24th Annual Spring Conference
6. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
7. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
8. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
9. Archimedes Inc. Renews Annual Marketing Agreement with HealthEconomics.Com
10. Palatin Technologies To Present At The 25th Annual ROTH Conference
11. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2015)... ... , ... Technology leader Anton Paar offers the Abbemat ... temperature of the measuring prism. This is required to achieve the most precise ... key requirements. It is likely that no refractometer manufacturers on the market can ...
(Date:7/24/2015)... SAN DIEGO , July 24, 2015 ... corporate and financial results for the second quarter 2015 ... the announcement, Orexigen will provide a business update and ... conference call at 8:00 a.m. Eastern Time (5:00 a.m. ... accessed by phone by calling (800) 447-0521 (domestic) or ...
(Date:7/23/2015)... 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... the second quarter 2015 on Thursday, August 6, 2015. The ... on that day at 5:00 pm ET to discuss the ... The call will be hosted by Andrew Gengos , ... , , LIVE CALL: , , ,  (877) 853-5636 ...
(Date:7/23/2015)... ... July 23, 2015 , ... July 23, 2015, Chicago - ... treatment options with fewer side effects, according to Erik P. Sulman, MD, PhD, ... At the American Brain Tumor Association (ABTA) National Patient and Family Conference in ...
Breaking Biology Technology:It’s T-Time for Refractometers: On-site Temperature Check Now Available 2ImmunoCellular Therapeutics to Report Second Quarter 2015 Financial Results on August 6, 2015 2Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 2Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 3
... , ... CEO, Matthew Sarad, plans a series of experiments to demonstrate the power of nanotechnology ... ... Mr. Matthew Sarad, has announced plans to attempt to rejuvenate living animals with advanced ...
... HORSHAM, Pa., Sept. 10 Centocor Ortho Biotech Products, L.P. ... U.S. Food and Drug Administration (FDA) regarding its Supplemental New Drug ... in combination with docetaxel for the treatment of women with ... Centocor Ortho Biotech is evaluating the FDA,s letter and ...
... , ABBOTT PARK, Ill. and MENLO ... announced today a definitive agreement to acquire the outstanding equity of ... minimally invasive repair of cardiac mitral valves. The acquisition provides ... for structural heart disease, in which physicians use catheter-based devices to ...
Cached Biology Technology:Matthew Sarad to Reverse Aging and Cure Cancer 2Matthew Sarad to Reverse Aging and Cure Cancer 3Matthew Sarad to Reverse Aging and Cure Cancer 4Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer 2Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer 3Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer 4Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer 5Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology 2Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology 3Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology 4
(Date:6/25/2015)... 2015  Imagine a tool specifically designed to help ... life. That,s exactly what USANA,s True Health Assessment ... portable health program provides a personalized approached to measuring ... your lifestyle and nutrition. At the ... night, USANA,s THA was honored with the Industry Innovation ...
(Date:6/24/2015)... NEW YORK , June 24, 2015 ... Systems market, over the next six years. It contains ... affect the industry, along with their impact from the ... It also discusses the industry, market, and technology ... expected that the need of concerned authorities to efficiently ...
(Date:6/24/2015)... 24, 2015 Biometry authentication provider KeyLemon ... password solution one face in. ... one face in, entering the expanding biometric authentication ... multifactor-authentication biometric answer to the password problem. With ... partnership with KeyLemon, one face in allows users ...
Breaking Biology News(10 mins):@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... Resources, one of the world,s leading research and advisory ... most of the biomarker-drug success stories are in oncology, ... chronic conditions, and their use in clinical trials of ... report entitled Driving Drug and Diagnostic R&D: ...
... 2013 -- Researchers have identified some of the underlying physics ... a stall in midflight -- unlike conventional fixed wing aircraft, ... The analysis, in which the researchers studied the ... how insects fly and informs the design of small flying ...
... 2013 A bicoastal group of scientists at Sanford-Burnham ... grant from the U.S. Department of the Air Force ... chemicals. The goal of the project is to provide ... a rapid, cost-effective manner. "The current approach to ...
Cached Biology News:Use of Biomarkers in Clinical Trials for Drugs Outside of Oncology is Increasing 2Sanford-Burnham receives US Air Force grant to perform next-generation toxicity screens 2
... ChipWriter Pro system, 220-240 V, uses floating ... oligonucleotides, carbohydrates, lipids, and other biomolecules onto ... This system can generate high-density arrays with ... or greater than 57,000 spots per membrane ...
... ProteinChip arrays have been developed for ... samples. A variety of ProteinChip chemical ... according to their unique biochemical properties. ... allowing side-by-side sample comparison, and the ...
The SmartSpec printer paper is used to record data generated by the SmartSpec Plus spectrophotometer. Supplied as 5 packs....
... been developed for affinity capture of ... of ProteinChip chemical surfaces allow differential ... unique biochemical properties. Each chip has ... comparison, and the chips are color-coded ...
Biology Products: